220 related articles for article (PubMed ID: 32071398)
21. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
[TBL] [Abstract][Full Text] [Related]
22. Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism.
Yu L; Sun Y; Li J; Wang Y; Zhu Y; Shi Y; Fan X; Zhou J; Bao Y; Xiao J; Cao K; Cao P
J Exp Clin Cancer Res; 2017 Aug; 36(1):110. PubMed ID: 28810896
[TBL] [Abstract][Full Text] [Related]
23. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
[TBL] [Abstract][Full Text] [Related]
25. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
26. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
28. Identification of α-taxilin as an essential factor for the life cycle of hepatitis B virus.
Hoffmann J; Boehm C; Himmelsbach K; Donnerhak C; Roettger H; Weiss TS; Ploen D; Hildt E
J Hepatol; 2013 Nov; 59(5):934-41. PubMed ID: 23816704
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.
Lee WY; Bachtiar M; Choo CCS; Lee CG
Biol Rev Camb Philos Soc; 2019 Apr; 94(2):353-367. PubMed ID: 30105774
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma.
Li K; Shen B; Cheng X; Ma D; Jing X; Liu X; Yang W; Peng C; Qiu W
Cancer Res; 2016 Jul; 76(14):4205-15. PubMed ID: 27267910
[TBL] [Abstract][Full Text] [Related]
31. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
32. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
33. Expressions of MiR-132 in patients with chronic hepatitis B, posthepatitic cirrhosis and hepatitis B virus-related hepatocellular carcinoma.
Liu B; Yang XF; Liang XP; Wang L; Shao MM; Han WX; Wu YH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8431-8437. PubMed ID: 30556884
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
35. [Hepatitis B virus integration and oncogene activation].
Koike K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2152-63. PubMed ID: 3038033
[TBL] [Abstract][Full Text] [Related]
36. [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
Longerich T
Pathologe; 2014 Nov; 35 Suppl 2():177-84. PubMed ID: 25394965
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma.
Liu Y; Feng J; Sun M; Yang G; Yuan H; Wang Y; Bu Y; Zhao M; Zhang S; Zhang X
Cancer Lett; 2019 Jul; 454():158-170. PubMed ID: 30981758
[TBL] [Abstract][Full Text] [Related]
38. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
39. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma.
Kim YR; Byun MR; Choi JW
Cancer Biomark; 2018; 23(1):135-144. PubMed ID: 30010110
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]